Magnesium Chloride Dr — supply status, manufacturers & alternatives

Magnesium Chloride Dr

—

In supply · Australia

In supply · 🇦🇺 Australia · short in🇺🇸 US

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Patient information leaflet (PIL)
Active ingredient (INN)	Magnesium Chloride Dr
Therapeutic category	Auto-created by FDA Drug Enforcement — Full Recall Database scraper
Controlled substance	No

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Recalls official enforcement reports

🇺🇸

MAGNESIUM SULFATE

Amneal Pharmaceuticals, LLC · Mar 2026

Class Idetails ↗

🇺🇸

Magnesium Chloride Hexahydrate (Pfv) 20% Inj Soln

RXQ Compounding LLC · June 2019

Class IIdetails ↗

🇺🇸

Magnesium Chloride Hexahydrate (Mdv) 20% Inj Soln

RXQ Compounding LLC · June 2019

Class IIdetails ↗

🇺🇸

Magnesium Citrate Oral Solution Lemon Flavor

Vi-Jon, Inc. · Sept 2017

Class IIIdetails ↗

🇺🇸

Magnesium Citrate Oral Solution Cherry Flavor

Vi-Jon, Inc. · Sept 2017

Class IIIdetails ↗

🇺🇸

Magnesium Citrate Saline Laxative Cherry Flavored

Vi-Jon, Inc. · June 2017

Class IIdetails ↗

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.